The success of biopharma and medtech are not mutually exclusive. In some ways, medtech is actually drafting off of the recent surge in interest and investment in biopharma.
Partnerships with consumer-tech firms could help medtech companies innovate and stay relevant as healthcare turns increasingly to prevention and wellness, according to a new report from Deloitte.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.